These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11378373)

  • 1. Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.
    Dhanak D; Christmann LT; Darcy MG; Jurewicz AJ; Keenan RM; Lee J; Sarau HM; Widdowson KL; White JR
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1441-4. PubMed ID: 11378373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
    Dhanak D; Christmann LT; Darcy MG; Keenan RM; Knight SD; Lee J; Ridgers LH; Sarau HM; Shah DH; White JR; Zhang L
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1445-50. PubMed ID: 11378374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.
    De Lucca GV; Kim UT; Johnson C; Vargo BJ; Welch PK; Covington M; Davies P; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2002 Aug; 45(17):3794-804. PubMed ID: 12166951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist.
    Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):697-701. PubMed ID: 12808249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
    Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel CCR3 selective antagonist.
    Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
    Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
    Varnes JG; Gardner DS; Santella JB; Duncia JV; Estrella M; Watson PS; Clark CM; Ko SS; Welch P; Covington M; Stowell N; Wadman E; Davies P; Solomon K; Newton RC; Trainor GL; Decicco CP; Wacker DA
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1645-9. PubMed ID: 15026042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
    Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
    Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel CCR3 antagonists.
    Gong L; Hogg JH; Collier J; Wilhelm RS; Soderberg C
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3597-600. PubMed ID: 14505678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
    Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
    De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in CCR3 antagonists.
    De Lucca GV
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):516-24. PubMed ID: 16889234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potent and nonpeptidyl ccr3 antagonist.
    Saeki T; Ohwaki K; Naya A; Kobayashi K; Ishikawa M; Ohtake N; Noguchi K
    Biochem Biophys Res Commun; 2001 Mar; 281(3):779-82. PubMed ID: 11237726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.
    Pruitt JR; Batt DG; Wacker DA; Bostrom LL; Booker SK; McLaughlin E; Houghton GC; Varnes JG; Christ DD; Covington M; Das AM; Davies P; Graden D; Kariv I; Orlovsky Y; Stowell NC; Vaddi KG; Wadman EA; Welch PK; Yeleswaram S; Solomon KA; Newton RC; Decicco CP; Carter PH; Ko SS
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2992-7. PubMed ID: 17418570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
    Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
    J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.
    Das AM; Vaddi KG; Solomon KA; Krauthauser C; Jiang X; McIntyre KW; Yang XX; Wadman E; Welch P; Covington M; Graden D; Yeleswaram K; Trzaskos JM; Newton RC; Mandlekar S; Ko SS; Carter PH; Davies P
    J Pharmacol Exp Ther; 2006 Jul; 318(1):411-7. PubMed ID: 16614169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.